ID
28074
Description
Activity & Safety Study of Lenalidomide & Rituximab as Non-chemotherapy Based Therapy on Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01185262
Link
https://clinicaltrials.gov/show/NCT01185262
Keywords
Versions (1)
- 12/14/17 12/14/17 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
December 14, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Chronic Lymphocytic Leukemia NCT01185262
Eligibility Chronic Lymphocytic Leukemia NCT01185262
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Serology positive Hepatitis B | Exception HBsAg Patients Vaccinated
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0242089
- UMLS CUI [1,2]
- C0019163
- UMLS CUI [2,1]
- C1705847
- UMLS CUI [2,2]
- C0019168
- UMLS CUI [2,3]
- C0030705
- UMLS CUI [2,4]
- C1519885
Description
Pregnancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
Description
HIV Infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0019693
Description
Chemotherapy | Immunotherapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0392920
- UMLS CUI [2]
- C0021083
Description
Cancer Other | Exception Skin carcinoma Localized
Data type
boolean
Alias
- UMLS CUI [1]
- C1707251
- UMLS CUI [2,1]
- C1705847
- UMLS CUI [2,2]
- C0699893
- UMLS CUI [2,3]
- C0392752
Description
Neurologic Deficits Exclude Comprehension Study Protocol
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0521654
- UMLS CUI [1,2]
- C0332196
- UMLS CUI [1,3]
- C0162340
- UMLS CUI [1,4]
- C2348563
Description
Renal Insufficiency Requirement Dialysis
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1565489
- UMLS CUI [1,2]
- C1514873
- UMLS CUI [1,3]
- C0011946
Similar models
Eligibility Chronic Lymphocytic Leukemia NCT01185262
- StudyEvent: Eligibility
C0278791 (UMLS CUI [2])
C1514463 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C1268902 (UMLS CUI [3,3])
C0232804 (UMLS CUI [2])
C0004764 (UMLS CUI [1,2])
C0019163 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0019168 (UMLS CUI [2,2])
C0030705 (UMLS CUI [2,3])
C1519885 (UMLS CUI [2,4])
C0021083 (UMLS CUI [2])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C0392752 (UMLS CUI [2,3])
C0332196 (UMLS CUI [1,2])
C0162340 (UMLS CUI [1,3])
C2348563 (UMLS CUI [1,4])
C1514873 (UMLS CUI [1,2])
C0011946 (UMLS CUI [1,3])